personalized cancer vaccine, researchers reported Feb. 5. The small, phase 1 trial was carried out by the Dana-Farber Cancer Institute, with the results published in Nature on Wednesday.

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the vaccine candidate appeared to be safe and produced a clear immune ...

A new personalized immunotherapy treatment called a cancer vaccine has shown promising results in a phase I trial in people with kidney cancer. The results from nine patients treated at Dana ...

Personalized cancer vaccines showed significant immune responses in stage III/IV renal cell carcinoma patients, with T-cells increasing 166-fold and persisting for up to three years. The vaccine ...

The global fight against cancer is at a pivotal moment. A breakthrough in Russia promises to redefine cancer treatment, with the country announcing its first mRNA cancer vaccine. This revolutionary ...

THURSDAY, Feb. 6, 2025 (HealthDay News) -- A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, researchers report. The ...

Oncology vaccines have a wide potential to treat various kinds of cancer, even Vaccitech’s VTP-600 candidate going through clinical trials in lung cancer could potentially be repurposed to focus ...

Copyright 2025 The Associated Press. All Rights Reserved. The Parvo virus, which causes severe illness in dogs, has been spreading more rapidly across the country. A ...

Nine patients with advanced kidney cancer who received an experimental vaccine tailored to their tumors’ specific mutations mounted an immune response to their disease and remained cancer-free ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults.